Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis A Prospective, Multi-centre, Non-randomized Clinical Trial With Follow-up Investigations at 1, 6 and 12 Months.

Trial Profile

Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis A Prospective, Multi-centre, Non-randomized Clinical Trial With Follow-up Investigations at 1, 6 and 12 Months.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 May 2013

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Angina pectoris; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms PEPPER
  • Most Recent Events

    • 21 May 2012 12-Month results were presented at the EuroPCR congress in May 2012.
    • 10 Nov 2011 12-month results reported at the Transcatheter Cardiovascular Therapeutics 23rd Annual Scientific Symposium, according to a BIOTRONIK media release.
    • 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top